跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
破伤风人免疫球蛋白 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Human Tetanus Immunoglobulin
Approved
生物制品
Human Tetanus Immunoglobulin
Hualan Biological Engineering, Inc.
🇨🇳 National Medical Products Administration
Approval Date
May 14, 2020
Approval ID
7LeaeMrl1a4
Company
Hualan Biological Engineering, Inc.
Type
生物制品
Approval Details
Approval Id
7LeaeMrl1a4
Approval Number
国药准字S20023036
Generic Name
破伤风人免疫球蛋白
Generic Name En
Human Tetanus Immunoglobulin
Drug Type
生物制品
Dosage Form
注射剂
Strength
250IU/瓶(2.5ml)每瓶含破伤风抗体250IU,装量2.5ml。或250IU/支(2.5ml)每支含破伤风抗体250IU,装量2.5ml。
Reg Date
2020-05-14
Company Name
Hualan Biological Engineering, Inc.
Company Address
新乡市华兰大道甲1号
Production Company Name
Hualan Biological Engineering, Inc.
Production Company Address
河南省新乡市华兰大道甲1号
Company Detail Path
/organization/hualan-biological-engineering-inc
Production Company Detail Path
/organization/hualan-biological-engineering-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 14, 2020
Approval ID
7LeaeMrl1a4
Type
生物制品
Back to NMPA Approvals